Colon News and Research

RSS

Home treatment improves chronic constipation in children

Home treatment with a simple, battery-operated system that applies four sticky electrode patches to the mid-section allowed a group of children with the most difficult-to-treat, possibly congenital, constipation to reduce soiling and improve elimination, according to results presented today at the 11th World Congress of the International Neuromodulation Society.

12 Jun 2013

State highlights: Medi-Cal rate cuts loom; Latin American docs help meet need

In an office decorated with Chinese art and diagrams of body parts, Dr. George Ma cares for more than 4,000 patients. Nearly three-quarters are covered by Medi-Cal, the state's public insurance program for low-income Californians, and Ma said he receives $10 a month to treat most of them (Gorman and York, 6/10).

12 Jun 2013

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk -- according to a study of endoscopes used at five hospitals across the U.S.

10 Jun 2013

New non-invasive test measures methylation of SDC2 gene, detects 87% of colorectal cancer

The average 5-year survival for colorectal cancer (CRC) is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene in tissues and blood sera.

10 Jun 2013

Genetic testing for cancer-causing mutations in affected families is very low, study finds

A new study of the use of genetic testing for cancer-causing mutations in affected families in France has found that its take-up is very low.

10 Jun 2013

Diagnoplex secures 1.3 million Swiss francs from financing round

Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group™, with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that Diagnoplex has secured 1.3 million Swiss francs from a financing round led by Debiopharm.

7 Jun 2013

Molecular subtyping can predict chemotherapy benefit in patients with colorectal cancer

Molecular subtyping can help predict outcomes and chemotherapy benefit in patients with colorectal cancer, according to a presentation at the annual conference of the American Society of Clinical Oncology (ASCO).

6 Jun 2013

ACR urges Americans not to forego recommended screening for colorectal cancer

The American College of Radiology strongly urges Americans ages 50-and-older, particularly those with a family history of colorectal cancer, not to delay or forego recommended screening due to concerns raised by a June 1, New York Times article titled, "The $2.7 Trillion Medical Bill."

6 Jun 2013

Obese mothers can make impact on birth weight, diabetes risk of grandchildren: Study

Health problems linked to obesity - like heart disease and diabetes - could skip an entire generation, a new study suggests.

6 Jun 2013

Cook Medical receives clearance for Evolution® biliary controlled-release uncovered stent

The Food and Drug Administration has granted 510(k) clearance for the Evolution® Biliary Controlled-Release Uncovered Stent from Cook Medical. The biliary stent adds to Cook’s line of Evolution controlled-release stents for the gastrointestinal (GI) tract. It is the only delivery system that allows the stent to be deployed or recaptured as needed, putting control in the physician’s hands.

5 Jun 2013

Johns Hopkins researchers find interstate variations in rates of emergency bowel surgeries

Johns Hopkins researchers have documented huge and somewhat puzzling interstate variations in the percentage of emergency versus elective bowel surgeries. Figuring out precisely why the differences occur is critical, they say, because people forced to undergo emergency procedures are far more likely to die from their operations than those able to plan ahead for them.

5 Jun 2013

Researchers demonstrate how modified citrus pectin works against cancer

A new review by researchers at the University of Maryland School of Medicine highlights a large body of published research demonstrating how modified citrus pectin, works against cancer.

4 Jun 2013

Report: 83% of cancer doctors face oncology drug shortages

Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).

4 Jun 2013

Study brings researchers one step closer to personalized colorectal cancer treatment

MET protein levels correlate strongly with epithelial-mesenchymal transition phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.

4 Jun 2013

Nearly 2/3 of solid tumors carry at least one mutation that may be targeted by existing compound

Nearly two-thirds of solid tumors carry at least one mutation that may be targeted, or medicated, by an existing compound, according to new findings from researchers Fox Chase Cancer Center that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on June 3.

1 Jun 2013

RBC transfusion during cardiac surgery can increase risk of postoperative infection

The risk of postoperative infection appears to increase when patients receive red blood cell (RBC) transfusion during or after cardiac surgery, and greater attention to practices that limit red blood cell use could potentially reduce the occurrence of major postoperative infections, according to a study published in the June 2013 issue of The Annals of Thoracic Surgery.

1 Jun 2013

New therapy for lung cancer produces manageable side effects

A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center will present at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1.

1 Jun 2013

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

A new partnership, first of its kind for both organizations, will see Roswell Park Cancer Institute and Jasco Pharmaceuticals, LLC collaborating to advance development of an investigational pharmacological therapy that shows promise for treating both solid-tumor cancers and hematologic malignancies.

1 Jun 2013

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Agendia, a world leader in molecular cancer diagnostics, today announced that results from five studies focused on breast, colon and colorectal cancer will be presented at the upcoming American Society of Clinical Oncology Annual Meeting to be held May 31-June 4, 2013 at McCormick Place in Chicago.

1 Jun 2013

Three easy steps for cancer survivorship

Incorporating just three easy steps into a daily routine can increase a cancer patient's chance at survival, according to a physician who specializes in cancer survivorship.

31 May 2013

Colon News and Research

Home treatment improves chronic constipation in children

State highlights: Medi-Cal rate cuts loom; Latin American docs help meet need

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

New non-invasive test measures methylation of SDC2 gene, detects 87% of colorectal cancer

Genetic testing for cancer-causing mutations in affected families is very low, study finds

Diagnoplex secures 1.3 million Swiss francs from financing round

Molecular subtyping can predict chemotherapy benefit in patients with colorectal cancer

ACR urges Americans not to forego recommended screening for colorectal cancer

Obese mothers can make impact on birth weight, diabetes risk of grandchildren: Study

Cook Medical receives clearance for Evolution® biliary controlled-release uncovered stent

Johns Hopkins researchers find interstate variations in rates of emergency bowel surgeries

Researchers demonstrate how modified citrus pectin works against cancer

Report: 83% of cancer doctors face oncology drug shortages

Study brings researchers one step closer to personalized colorectal cancer treatment

Nearly 2/3 of solid tumors carry at least one mutation that may be targeted by existing compound

RBC transfusion during cardiac surgery can increase risk of postoperative infection

New therapy for lung cancer produces manageable side effects

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Three easy steps for cancer survivorship

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News